| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45K | — | +25.3% |
| R&D Expense | $48K | — | -90.8% |
| SG&A Expense | $194K | — | +72.4% |
| Operating Income | -$795K | — | +35.5% |
| Pre-tax Income | -$777K | — | +37.6% |
| Income Tax | $16K | — | +0.0% |
| Net Income | -$777K | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26K | -66.0% | -68.4% |
| Accounts Receivable | $128K | +2.9% | — |
| Current Assets | $266K | -15.9% | +77.4% |
| Total Assets | $4.1M | +2.3% | +2422.6% |
| Current Liabilities | $6.7M | +14.8% | +980.0% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$245K | — | +75.3% |
| Capital Expenditures | $28K | — | +89.9% |
| Investing Cash Flow | -$459K | — | -1113.8% |
| Financing Cash Flow | $653K | — | -40.7% |
| Free Cash Flow | -$273K | — | +72.8% |
| +38.3% |
| EPS (Basic) | -$0.01 | — | +50.0% |
| EPS (Diluted) | -$0.01 | — | +50.0% |
| $6.7M |
| +14.8% |
| +980.0% |
| Stockholders' Equity | -$2.6M | -42.6% | -465.3% |